Cannabis stocks have begun listing on major United States exchanges, driven by regulatory momentum following the rescheduling of medical cannabis.
This shift opens new avenues for institutional investment and greater liquidity in a sector long confined to over-the-counter markets. Companies now position themselves to attract broader capital as federal changes ease longstanding barriers.
Glass House Brands (NYSE: GLAS) has become the second U.S. cannabis company to uplist to the NYSE, following Trulieve Cannabis Corp (NYSE: TRLV) (FRA: T0A). Shares under the ticker GLAS began trading on Jun. 30 after approval. Both companies restructured operations to emphasise medical cannabis activities and meet exchange requirements.
“Now people from around the world can partner with us and own Glass House Brands with us,” said chief executive Kyle Kazan.
Trulieve, which started trading as TRLV on Jun. 10, has experienced solid volumes often exceeding 900,000 shares daily, with price gains reflecting increased visibility. Glass House saw notable pre-listing strength, with shares trading in the US$12.00 range amid rising interest and a market capitalisation near or above US$1 billion at peaks. Early trading volumes have increased as the new listing draws attention, although both stocks reflect the sector’s sensitivity to state regulations and reform developments.
“It’s happened,” commented market analyst and major shareholder Marc Cohodes, “for all the lovers, haters, trolls and skeptics, today is one to remember. Congratulations to the Glass House team.”
The listings represent concrete progress for the industry. Leaders at both firms link the moves directly to rescheduling, which enabled compliance. Glass House, a major California cultivator, points to potential growth through interstate commerce and medical exports. Trulieve, a leading Florida operator, highlights expanded shareholder reach and industry legitimacy.
Select additional operators stand out as likely candidates for future NYSE listings. Curaleaf Holdings Inc (TSE: CURA) (OTCMKTS: CURLF) and Verano Holdings Corp (OTCMKTS: VRNOF) (FRA: 76U0) have completed reverse stock splits to address share-price criteria, while Green Thumb Industries Inc (CNSX: GTII) (OTCMKTS: GTBIF) (FRA: R9U2) and Cresco Labs Inc (CNSX: CL) (OTCMKTS: CRLBF) (FRA: 6CQ) draw attention for their operational scale and profitability.
Big day for Glass House farms and the California cannabis industry. The first to the @NYSE ! Today they uplist and American investors can finally invest in the growing US cannabis industry. I went to their investor meeting to find out what rescheduling means for them. $GLAS -… pic.twitter.com/Z8iN0OZ4MU
— Ross Gerber (@GerberKawasaki) June 30, 2026
Read more: Tilray strengthens medical cannabis reach with HelloMD acquisition
Follow Rowan Dunne on LinkedIn
rowan@mugglehead.com